BioSpace News Archive

CEL-SCI Corporation (NYSE American: CVM) today announced the American Society of Clinical Oncology (ASCO) has published two abstracts related to CEL-SCI’s pivotal Phase 3 Multikine® (Leukocyte Interleukin, Inj.)* head and neck cancer clinical trial.

Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), today announced that the VAL-083 treatment arm in the Global Coalition for Adaptive Research (GCAR) registrational Phase 2/3 clinical trial for glioblastoma (GBM), titled Glioblastoma Adaptive Global Innovative Learning Environment (GBM AGILE), has activated its first European site, University Hospital Zurich in Zurich, Switzerland.

OriCell Therapeutics Co., Ltd (OriCell), today announced that an abstract detailing data from a Phase I study(POLARIS) evaluating OriCAR-017 in patients with Relapsed/Refractory Multiple Myeloma will be presented an oral session at the upcoming 2022 ASCO Annual Meeting on Sunday, June 5th.

Asieris Pharmaceuticals (688176.SH), a global innovative biopharma company specializing in discovering and developing innovative drugs for the treatment of genitourinary tumors and other major diseases announced that ANTICIPATE Study will be presented at the 2022 American Society of Clinical Oncology (ASCO) annual meeting (3-7 June) in Chicago.

According to Vision Research Reports, the cochlear implant market size is projected to hit around US$ 13.4 billion by 2030 from valued at US$ 8.70 billion in 2020, growing at a CAGR of 15.8% during the forecast period 2021 to 2030.

According to Vision Research Reports, the diabetes devices market size is expected hit around US$ 51.6 billion by 2030 from valued at US$ 33.0 billion in 2020 and is anticipated to grow at a CAGR of 11.8% during forecast period 2021 to 2030.

Jacobio Pharma (1167.HK) is pleased to announce that the phase I clinical data of KRAS G12C inhibitor JAB-21822 will be presented in the form of poster at the upcoming 2022 annual meeting of American Society of Clinical Oncology (ASCO) from June 3, 2022 to June 7, 2022.

Humic Acid Market size was USD 707.5 million in 2020 and is expected to register a steady revenue CAGR of 5.9% during the forecast period.

City of Hope, one of the largest cancer research and treatment organizations in the United States, announced it would present research on promising treatments for bladder and blood cancers, as well as studies on precision medicine and an experimental cancer vaccine, at the 2022 American Society of Clinical Oncology’s annual conference from June 3 to 7 in Chicago.

PetDx® – The Liquid Biopsy Company for Pets™ is participating in the Stifel 2022 Jaws & Paws Conference taking place in New York City on Wednesday, June 1, 2022.